Antimicrobial Peptides Market Size is valued at USD 248.53 Mn in 2024 and is predicted to reach USD 759.86 Mn by the year 2034 at a 11.9% CAGR during the forecast period for 2025-2034.
AMPs possess the ability to eliminate microbial pathogens directly; others function indirectly by modulating host defense systems. Natural antimicrobial peptides are found in bacterial and eukaryotic defense systems. They defend against bacteria, viruses, and fungi. They target cytoplasmic membranes, cell walls, DNA, and proteins, hence their composition is crucial. Direct-to-Consumer genetic testing is in demand due to better understanding of its benefits, such as tracing ancestry, assessing sickness risks, and delivering personalized healthcare information.
The increased awareness of medications and therapies incorporating antimicrobial peptides is anticipated to enhance the global market for such peptides significantly. Chronic conditions where antibiotic resistance remains ineffectual offer particularly attractive opportunities for antimicrobial peptide manufacturers. Moreover, continual advancements in biotechnology are streamlining the development and production processes of antimicrobial peptides, thereby facilitating market expansion. There is a growing acknowledgment of infection control measures, particularly within healthcare settings, driving the demand for antimicrobial peptides as effective solutions.
Additionally, persistent investments in research and development activities are driving the discovery and innovation of new antimicrobial peptides, thus maintaining market momentum. Additionally, stringent regulatory standards governing the approval process of antimicrobial peptides pose challenges, potentially leading to delays in market entry and increased development costs. Despite promising research findings, not all antimicrobial peptides smoothly transition from experimental stages to viable commercial products, introducing uncertainties regarding their market viability.
The antimicrobial peptides market is categorized on the basis of product , ailments distribution channel, route of administration and end users .Based on product, the antimicrobial peptides market is segmented as plant antimicrobial peptides, bacterial antimicrobial peptides, animal antimicrobial peptides, and insect antimicrobial peptides .Based on Ailments, the market is segmented as pneumonia, hepatitis, bacterial infections, HIV). Based on Distribution Channel, the Antimicrobial Peptides market is segmented as Hospital, Research Institutes, Specialty Clinic, and Pharmacies. Based on route of administration the antimicrobial peptides market is segmented as topical, subcutaneous, intravenous, Based on end users. the antimicrobial peptides market is divided into pharma and healthcare, the agriculture industry, and biological engineering.
The Pharma and Healthcare category is expected to hold a major share of the global Antimicrobial Peptides Market in 2022. Pharmaceutical firms are becoming more aware of the promise of AMPs as innovative medicinal agents. They may be involved in the research, development, and production of AMP-based drugs to address bacterial infections. These companies may either develop AMPs in-house or collaborate with biotechnology firms specializing in peptide therapeutics. The increasing adoption of AMPs by Pharma and Healthcare as end users reflects the growing recognition of AMPs as valuable tools in the fight against bacterial infections and the need for innovative therapeutic options in the field of antimicrobial therapy.
The hospital segment is projected to develop at a rapid rate in the global antimicrobial peptides market. Hospitals are increasingly playing a more prominent role in the distribution of antimicrobial peptides (AMPs). Traditionally, pharmaceutical products, including antimicrobial agents, were primarily distributed through pharmaceutical wholesalers and distributors. However, as the demand for specialized therapeutic products like AMPs grows, hospitals are increasingly becoming direct purchasers and distributors of these products.
The North American Antimicrobial Peptides Market: the market is projected to record a large market revenue share. The anticipated surge in demand for antibiotics within this geographic area, coupled with a rise in research and development endeavors, is projected to propel the industry forward throughout the forecast period. Additionally, the Asia Pacific regional market is poised to witness the most rapid growth, attributable to factors such as the escalating prevalence of diverse infectious diseases, a burgeoning elderly population, and an upsurge in patient awareness regarding their health.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 248.53 Mn |
|
Revenue Forecast In 2034 |
USD 759.86 Mn |
|
Growth Rate CAGR |
CAGR of 11.9% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, Ailments, Route of Administration, Distribution Channel, End User, |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Novozymes A/S, Polypeptide Group, Bachem Holding AG, Wuxi Apptec, Ana Spec Inc. (a Eurofins Company), Merial, Ipsen S.A., AstraZenec, Pfizer Inc, GlaxoSmithKline plc, Merck & Co. Inc., Sandoz International GmbH, Polymedia, Magennis Inc., Probiotic Limited Melinta Therapeutics, LLC, Vertex Pharmaceuticals Incorporated, AMP Biotech, Phoenix Biotechnology Inc., Novabiotics and Others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Antimicrobial Peptides Market Snapshot
Chapter 4. Global Antimicrobial Peptides Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Plant Antimicrobial Peptides
5.2.2. Bacterial Antimicrobial Peptides
5.2.3. Animal Antimicrobial Peptides
5.2.4. Insect Antimicrobial Peptides
Chapter 6. Market Segmentation 2: by Ailments Estimates & Trend Analysis
6.1. by Ailments & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Ailments:
6.2.1. Pneumonia
6.2.2. Hepatitis
6.2.3. Bacterial infections
6.2.4. HIV
Chapter 7. Market Segmentation 3: by Route of Administration Estimates & Trend Analysis
7.1. by Route of Administration & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Route of Administration:
7.2.1. Topical
7.2.2. Subcutaneous
7.2.3. Intravenous
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By End User & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
8.2.1. Pharma and Healthcare
8.2.2. Agriculture Industry
8.2.3. Biological Engineering
8.2.4. Others
Chapter 9. Market Segmentation 5: by Distribution Channel Estimates & Trend Analysis
9.1. by Distribution Channel & Market Share, 2024 & 2034
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Distribution Channel:
9.2.1. Hospital
9.2.2. Research Institutes
9.2.3. Specialty Clinic
9.2.4. Pharmacies
Chapter 10. Antimicrobial Peptides Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Antimicrobial Peptides Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.1.2. North America Antimicrobial Peptides Market Revenue (US$ Million) Estimates and Forecasts by Ailments, 2021-2034
10.1.3. North America Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034
10.1.4. North America Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034
10.1.5. North America Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034
10.1.6. North America Antimicrobial Peptides Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Antimicrobial Peptides Market revenue (US$ Million) by Product Type, 2021-2034
10.2.2. Europe Antimicrobial Peptides Market revenue (US$ Million) by Ailments, 2021-2034
10.2.3. Europe Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034
10.2.4. Europe Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034
10.2.5. Europe Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034
10.2.6. Europe Antimicrobial Peptides Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) by Product Type, 2021-2034
10.3.2. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) by Ailments, 2021-2034
10.3.3. Asia-Pacific Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034
10.3.4. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034
10.3.5. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034
10.3.6. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Antimicrobial Peptides Market revenue (US$ Million) by Product Type, 2021-2034
10.4.2. Latin America Antimicrobial Peptides Market revenue (US$ Million) by Ailments, 2021-2034
10.4.3. Latin America Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034
10.4.4. Latin America Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034
10.4.5. Latin America Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034
10.4.6. Latin America Antimicrobial Peptides Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by Product Type, 2021-2034
10.5.2. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by Ailments, 2021-2034
10.5.3. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034
10.5.4. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034
10.5.5. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034
10.5.6. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Novozymes A/S
11.2.2. Polypeptide Group
11.2.3. Bachem Holding AG
11.2.4. Wuxi Apptec
11.2.5. Ana Spec Inc. (a Eurofins Company)
11.2.6. Merial
11.2.7. Ipsen S.A.
11.2.8. AstraZeneca
11.2.9. Pfizer Inc.
11.2.10. GlaxoSmithKline plc
11.2.11. Merck & Co. Inc.
11.2.12. Sandoz International GmbH
11.2.13. Polymedia
11.2.14. Magennis Inc.
11.2.15. Probiotic Limited
11.2.16. Eli Lilly and Company
11.2.17. Johnson & Johnson Private Limited
11.2.18. Melinta Therapeutics, LLC
11.2.19. Vertex Pharmaceuticals Incorporated
11.2.20. AMP Biotech
11.2.21. Phoenix Biotechnology Inc.
11.2.22. Novabiotics
11.2.23. Other prominent players
Antimicrobial Peptides Market By Product
Antimicrobial Peptides Market By Ailments
Antimicrobial Peptides Market By Route of Administration
Antimicrobial Peptides Market By End User
Antimicrobial Peptides Market By Distribution Channel
Antimicrobial Peptides Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
